Manipal Hospitals Enterprises-Fortis Deal: 10 Facts To Know
- Deal: As part of the proposed transaction, Manipal Education and Medical Group (MEMG) chairman Dr Ranjan Pai and US-based private equity firm TPG Capital, a shareholder in Manipal Hospitals since 2015, will invest Rs. 3,900 crore in Manipal Hospitals.
- The deal is subject to approval of regulators as well as Fortis and Manipal Hospitals Enterprises shareholders, the statement further said.
- India's biggest healthcare services provider: The combination of Manipal Hospitals and Fortis Hospitals will result in creation of the country's largest healthcare services provider by revenue.
- Hospitals: The combined entity will have a total of 41 hospitals in the country and four overseas. Currently, Fortis Healthcare has 31 hospitals while Manipal Hospitals has 10 hospitals in the country, according to Fortis Healthcare.
- Doctors: The combined entity - which will be a publicly traded company on the National Stock Exchange and Bombay Stock Exchange - will operate with a network of more than 4,200 doctors, according to a presentation by Fortis Healthcare released in its filing to the BSE.
- Employees: The entity - to be called Manipal Hospitals - will have more than 24,700 employees, with Fortis Healthcare having an over 15,850 strong workforce at present, and over 8,850 of Manipal Hospitals.
- The combination of Manipal and Fortis Hospitals can create significant value for all stakeholders, Fortis Healthcare said in a statement late on Tuesday.
- Fortis Healthcare termed the combination "a huge positive for the employees as it enables career growth and learning opportunities". It said both organisations "take a great deal of pride in having strong cultures and employee best practices".
- The funds will be utilized by Manipal Hospitals to finance the acquisition of 50.9 per cent stake in SRL. That comprises 20 per cent from Fortis Healthcare and 30.9 per cent from other investors. FHL will continue to hold 36.6 per cent of SRL and the remaining 12.5 per cent stake in SRL will be held by existing investors (including management).
- Manipal Hospitals, part of Manipal Education and Medical Group, is a hospital chain with a strong presence in the southern part of the country.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
